Department of Psychiatry and Psychotherapy I, Ulm University, Zentrum für Psychiatrie Südwürttemberg, Versorgungsforschung, Weingartshofer Straße 2, 88214, Ravensburg, Germany,
Soc Psychiatry Psychiatr Epidemiol. 2013 Nov;48(11):1787-96. doi: 10.1007/s00127-013-0687-x. Epub 2013 Apr 19.
The purpose of the study was to examine the long-term influence of involuntary hospitalization on medication adherence, engagement in out-patient treatment and perceived coercion to treatment participation.
In a naturalistic observational multi-centre study, 290 voluntarily and 84 involuntarily hospitalized patients with schizophrenia or schizoaffective disorder had been followed up over a period of 2 years with half-yearly assessments. Assessments included self-rated medication adherence, externally judged medication adherence by blood levels, engagement in treatment and perceived coercion. The statistical analyses were based on multilevel hierarchical modelling of longitudinal data. Level and development of the outcome was controlled for involuntariness, for sociodemographic characteristics and clinical history.
Involuntariness of the index-hospitalization did not have an effect on the development of treatment engagement or medication adherence judged by blood levels in the course of the follow-up period when the models were controlled for sociodemographic variables and clinical history. It was associated, though, with a continuously lower self-rated medication adherence. Moreover, former involuntarily hospitalized patients more often felt coerced in several treatment aspects at the follow-up assessments. Yet, there was no difference between the voluntary and involuntary group with regard to the development of the levels of adherence or coercion experiences over time.
Involuntary hospitalization does not seem to impair future treatment engagement in patients with schizophrenia, but formerly involuntarily hospitalized patients continue to be more sensitive to subjective or real coercion in their treatment and more vulnerable to medication non-adherence. Hereby, their risk of future involuntary hospitalization might be increased.
本研究旨在探讨非自愿住院对药物依从性、门诊治疗参与度和治疗参与感的影响。
在一项自然观察性多中心研究中,对 290 名自愿住院和 84 名非自愿住院的精神分裂症或分裂情感障碍患者进行了为期 2 年的随访,每半年进行一次评估。评估包括自我报告的药物依从性、血液水平评估的外部判断的药物依从性、治疗参与度和治疗参与感的强迫程度。统计分析基于纵向数据的多层次层次模型。在控制非自愿性、社会人口学特征和临床病史的情况下,对水平和结局的发展进行了分析。
在控制了社会人口学变量和临床病史后,指数住院的非自愿性对治疗参与度或血液水平评估的药物依从性的发展没有影响。然而,它与自我报告的药物依从性的持续降低有关。此外,以前非自愿住院的患者在随访评估中在几个治疗方面更常感到被迫。然而,自愿组和非自愿组在随时间变化的药物依从性或强迫经历水平上没有差异。
非自愿住院似乎不会损害精神分裂症患者未来的治疗参与度,但以前非自愿住院的患者在治疗中继续对主观或实际的强迫更为敏感,对药物不依从更为脆弱。因此,他们未来非自愿住院的风险可能会增加。